🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nils B. Jørgensen

Novo Nordisk (Denmark)

ORCID: 0000-0002-5764-6377
Health ProfessionsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial.

22 citations

Nils B. Jørgensen, Bharath Kumar, Ildiko Lingvay, Anne Sofie Laulund, John B. Buse +2 more